Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Depreciation & Amortization (CF): 2014-2024

Historic Depreciation & Amortization (CF) for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to $1.7 million.

  • AC Immune's Depreciation & Amortization (CF) rose 221.00% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 435.25%. This contributed to the annual value of $1.7 million for FY2024, which is 10.07% down from last year.
  • Latest data reveals that AC Immune reported Depreciation & Amortization (CF) of $1.7 million as of FY2024, which was down 10.07% from $1.9 million recorded in FY2023.
  • AC Immune's 5-year Depreciation & Amortization (CF) high stood at $2.1 million for FY2021, and its period low was $1.7 million during FY2024.
  • For the 3-year period, AC Immune's Depreciation & Amortization (CF) averaged around $1.8 million, with its median value being $1.9 million (2022).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 31.91% in 2020, then dropped by 10.35% in 2022.
  • Over the past 5 years, AC Immune's Depreciation & Amortization (CF) (Yearly) stood at $1.7 million in 2020, then increased by 22.26% to $2.1 million in 2021, then fell by 10.35% to $1.9 million in 2022, then climbed by 1.28% to $1.9 million in 2023, then declined by 10.07% to $1.7 million in 2024.